Hepatitis C virus inhibitors
US8288562B2 · kind B2 · utility
8Cited by
4References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 25, 2010 |
| Grant date | Oct 16, 2012 |
| Priority date | — |
| Expiry date | Aug 19, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F7/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.